KEY FEATURES
| Full Name | Defensin Alpha 1, Neutrophil |
|---|---|
| Synonym | DEF1; DEFA2; HNP-1; HP-1; MRS; DEF3; HNP-3; HNP3; HP-3; Defensin,Alpha 1; Myeloid-Related Sequence |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.31-20ng/mL |
| Sensitivity | 0.13ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human DEFa1 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human DEFa1. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human DEFa1 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human DEFa1, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human DEFa1. You can calculate the concentration of Human DEFa1 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES
TYPICAL DATA
Human DEFa1 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 1.03 | 3.15 | 8.77 | 0.95 | 3.42 | 8.38 |
| Standard deviation | 0.06 | 0.13 | 0.48 | 0.05 | 0.18 | 0.34 |
| CV(%) | 5.44 | 4.01 | 5.46 | 5.2 | 5.25 | 4.08 |
RECOVERY
The recovery of Human DEFa1 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 91-106 | 97 |
| EDTA plasma (n=8) | 93-105 | 100 |
| Cell culture media (n=8) | 93-109 | 101 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human DEFa1 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.
Products associated with DEFA1 ELISA Kits
| DEFA3 ELISA Kit | publications with DEFA1 and DEFA3 |
Pathways associated with DEFA1 ELISA Kit
| Alpha-defensins Pathway | Alpha-defensins Pathway |
| Cellular Roles Of Anthrax Toxin Pathway | Cellular Roles Of Anthrax Toxin Pathway |
| Defensins Pathway | Defensins Pathway |
| Immune System Pathway | Immune System Pathway |
| Innate Immune System Pathway | Innate Immune System Pathway |
Diseases associated with DEFA1 ELISA Kit
| Inflammation | publications with DEFA1 and Inflammation |
| Neoplasms | publications with DEFA1 and Neoplasms |
| Colitis | publications with DEFA1 and Colitis |
| Colorectal Neoplasms | publications with DEFA1 and Colorectal Neoplasms |
| Craniofacial Abnormalities | publications with DEFA1 and Craniofacial Abnormalities |
| Fibrosis | publications with DEFA1 and Fibrosis |
| Dyspnea | publications with DEFA1 and Dyspnea |
| Adenocarcinoma | publications with DEFA1 and Adenocarcinoma |
| Neoplasm Metastasis | publications with DEFA1 and Neoplasm Metastasis |
| Limb Deformities, Congenital | publications with DEFA1 and Limb Deformities, Congenital |
Organs/Tissues associated with DEFA1 ELISA Kit
| Blood | publications with DEFA1 and Blood |
| Bone | publications with DEFA1 and Bone |
| Liver | publications with DEFA1 and Liver |
| Bone Marrow | publications with DEFA1 and Bone Marrow |
